Showing results (1-10 of 15) with videos related to
Sort By:
Pageof 2
Journal of Medical Economics|March 2, 2013
Posaconazole vs fluconazole/itraconazole in the prophylaxis of invasive fungal infections in immunocompromised patients: a cost-effectiveness analysis in GreeceK Athanasakis, I Petrakis, J KyriopoulosCahiers De Sociologie Et De Demographie Medicales|April 27, 2000
[Physician workforce and population aging in Greece]J Kyriopoulos, D Andrioti, E GeorgoussiExpert Review of Pharmacoeconomics & Outcomes Research|March 12, 2017
Losing a foot versus losing a dollar; a systematic review of cost studies in diabetic foot complicationsIoannis Petrakis, Ilias J Kyriopoulos, Alexandros Ginis, et al.Community Dental Health|November 5, 2010
Social determinants of dental health services utilisation of Greek adultsE Pavi, E Karampli, D Zavras, et al.Hippokratia|January 7, 2014
Trends of mortality in Greece 1980-2007: a focus on avoidable mortalityM Ollandezos, Th Constantinidis, K Athanasakis, et al.Hippokratia|October 23, 2014
Pharmaceutical innovation: impact on expenditure and outcomes and subsequent challenges for pharmaceutical policy, with a special reference to GreeceE Karampli, K Souliotis, N Polyzos, et al.Prenatal Diagnosis|January 13, 1999
Economic evaluation of prenatal screening for Down syndrome in the U.S.AT Beazoglou, D Heffley, J Kyriopoulos, et al.Health Policy (Amsterdam, Netherlands)|January 23, 2017
Why do generic drugs fail to achieve an adequate market share in Greece? Empirical findings and policy suggestionsT Balasopoulos, A Charonis, K Athanasakis, et al.Journal of Clinical Pharmacy and Therapeutics|September 12, 2009
Generic medicines: Greek physicians' perceptions and prescribing practicesV Tsiantou, D Zavras, H Kousoulakou, et al.Diabetic Medicine : a Journal of the British Diabetic Association|June 16, 2010
Estimating the direct cost of Type 2 diabetes in Greece: the effects of blood glucose regulation on patient costK Athanasakis, M Ollandezos, A Angeli, et al.Pageof 2